Skip to main content

SLN Staging in Carcinoids and Neuroendocrine Tumors

  • Chapter
Book cover The Sentinel Lymph Node Concept
  • 1323 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adams S, Baum R, Rink T, Schumm-Drager PM, Usadel KH, Hor G (1998a) Limited value of fluorine-18 fiuorodeoxy-glucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25:79–83

    PubMed  Google Scholar 

  • Adams S, Baum RE, Hertel A, Wenish HJ, Staib-Sebler E, Herrmann G, Enke A, Hor G (1998b) Intraoperative gamma probe detection of neuroendocrine tumors. J Nucl Med 39:1155–1160

    PubMed  Google Scholar 

  • Ahlman H (1999) Surgical treatment of carcinoid tumors of the stomach and small intestine. Ital J Gastroenterol Hepatol 31[Suppl 2]:S198–S201

    PubMed  Google Scholar 

  • Angelitti S, Corleto VD, Schillaci O, Moretti A, Panzuto F, Annibale B, Delle Fave G (1999) Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumors. Ital J Gastroenterol Hepatol 31:23–27

    PubMed  Google Scholar 

  • Arrigoni MG, Woolner LB, Bernatz PE (1972) Atypical carcinoid tumours of the lung. J Thorac Cardiovasc Surg 64:413–421

    PubMed  Google Scholar 

  • Aures D, Håkanson R, Schauer A (1968) Histidine decarboxylase and DOPA decarboxylase in the rat stomach. Properties and cellular localization. Eur J Pharmacol 3:217–234

    Article  PubMed  Google Scholar 

  • Banzo J, Abos MD, Prats E, Delgado M, Razola P, Garcia S, Gomollon F, Garcia F (2001) The scintigraphy of somatostatin receptors in the carcinoid tumor. Rev Esp Med Nucl 20:11–18

    PubMed  Google Scholar 

  • Bonato M, Cerati M, Pagani A, Papotti M, Bosi F, Bussolati G, Capella C (1992) Differential diagnostic patterns of lung neuroendocrine tumours. A clinico-pathological and immunohistochemical study of 122 cases. Virchows Arch [A] 420:201–211

    Google Scholar 

  • Bordi C (1999) Gastric carcinoids. Ital J Gastroenterol Hepatol 31[Suppl 2]:S94–S97

    PubMed  Google Scholar 

  • Brandt-Mainz K, Müller SP, Gorges R, Sailer B, Bockisch A (2000) The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer. Eur J Nucl Med 27:490–496

    Article  PubMed  Google Scholar 

  • Brundler R, Gebbers JO, Criblez D (1999) Multiple gastric carcinoid tumors in chronic atrophic gastritis: long-term follow-up under conservative management. Schweiz Med Wochenschr 129(25):957–960

    PubMed  Google Scholar 

  • Capella C, Heitz P, Höfler H, Solcia E, Klöppel G (1995) Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 425:547–560

    Article  PubMed  Google Scholar 

  • Casini Raggi C, Pinzani P, Gelmini S, Tricarico C, Orlando C, Calabro A, Renzi D, Cianchi F, Valanzano R, Distante V, Cortesini C, Tonelli F, Cataliotti L, Cameron Smith M, Messerini L, Bianchi S, Pazzagli M, Serio M, Maggi M (2001) Somatostatin receptors in non-endocrine tumors. Minerva Endocrinol 26:149–158

    PubMed  Google Scholar 

  • Chatziioannou A, Kehagias D, Mourikis D, Antoniou A, Limouris G, Kaponis A, Kavatzas N, Tseleni S, Vlachos L (2001) Imaging and localization of pancreatic insulinomas. Clin Imaging 25(4):275–283

    Article  PubMed  Google Scholar 

  • Conti PS, Durski JM, Bacqai F, Grafton ST, Singer PA (1999) Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid 9:797–804

    PubMed  Google Scholar 

  • Debray MP, Geoffroy O, Laissy JP, Lebtahi R, Silbermann-Hoffman O, Henry-Reugeas MC, Cadiot G, Mignon M, Schouman-Claeys E (2001) Imaging appearance of metastases from neuroendocrine tumours of the pancreas. Br J Radiol 74(887):1065–1070

    PubMed  Google Scholar 

  • Garza Trasobares E, Muniesa Soriano JA, Lazaro Maisonave JM (1999) Multicentric gastric carcinoid tumor. Rev Esp Enferm Dig 91(6):456–457

    PubMed  Google Scholar 

  • Giammarile F, Baudin E, Tenenbaum F, Lumbroso J, Schlumberger M, Rougier P, Ruffle P, Guigay J, Ducreaux ML, Parmentier C (1995) Somatostatin receptor imaging: a preliminary experience in forty-nine patients. Q J Nucl Med 39(4) [Suppl 1]:121–123

    PubMed  Google Scholar 

  • Gibril F, Reynolds JC, Lubensky IA, Roy PK, Peghini PL, Doppman JL, Jesen RT (2000) Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study. J Nucl Med 41(10):1646–1656

    PubMed  Google Scholar 

  • Giovannini M, Pasquier J, Brenot-Rossi I, Perrier H, Sauvan R, Seits JF (1995) The role of echoendoscopy and scintigraphy of somatostatin receptors in the staging of neuro-endocrine digestive tumors. Ann Gastroenterol Hepatol (Paris) 31(2):109–113

    Google Scholar 

  • Gould VER, Linnoila I, Memoli VA, Warren WH (1983) Neuroendocrine cells and neuroendocrine neoplasms of the lung. Lab Invest 49:519–539

    PubMed  Google Scholar 

  • Herder WW de, Lamberts SW (2002) Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr Opin Oncol 14:53–57

    Article  PubMed  Google Scholar 

  • Hoefnagel CA (1994) Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med 21:561–581

    PubMed  Google Scholar 

  • Holler H (1997) Neuroendocrine Tumoren der Lunge (Neuroendocrine lung tumors). Verh Dtsch Ges Pathol 81:118–124

    PubMed  Google Scholar 

  • Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, Hagen M van, Postema PT, Jong M de, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ, Koper JW, Lamberts SWJ (1993) Somatostatin receptor scintigraphy with (111In-DTPA-D-Phe 1)-and (123I-Tyr 3)-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716–731

    Article  PubMed  Google Scholar 

  • Kulaksiz H, Eissele R, Rossler D, Schulz S, Hollt V, Cetin Y, Arnold R (2002) Identification of somatostatin receptor subtypes 1, 2A, 3 and 5 in neuroendocrine tumors with subtype specific antibodies. Gut 50:52–60

    Article  PubMed  Google Scholar 

  • Martelli H, Ricard M, Larroquet M, Wioland M, Paraf F, Fabre M, Josset P, Helardot PG, Gauthier F, Terrier-Lacombe MJ, Michon J, Hartmann O, Tabone MD, Patte C, Lumbroso J, Grüner M (1998) Intraoperative localization of neuroblastoma in children with I123 or I125 radiolabeled metaiodobenzylguanidine. Surgery 123:51–57

    Article  PubMed  Google Scholar 

  • Ohrvall U, Westlin JE, Nilsson S, Juhlin C, Rastard J, Lundquist H, Akerstrom G (1997) Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy. Cancer 80(12) [Suppl]:2490–2494

    Article  PubMed  Google Scholar 

  • Padberg BC, Städtler C, Schröder S (2000) Morphologic DNA-Zytophotometrie und Prognose gastrointestinaler neuroendokriner Tumoren (Karzinoide). Eine klinischpathologische Untersuchung an 95 Patienten. Pathologe 21:73–81

    Article  PubMed  Google Scholar 

  • Papotti M, Croce S, Bello M, Bongiovanni M, Allia E, Schindler M, Mussolati G (2001) Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumors. Correlation with preoperative octreotide scintigraphy. Virchows Arch 439: 787–797

    PubMed  Google Scholar 

  • Pasquali C, Rubello D, Sperti C, Gasparoni P, Lissi G, Chierichetti F, Ferlin G, Pedrazzoli S (1998) Neuroendocrine tumor imaging: can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behaviour? World J Surg 22:588–592

    Article  PubMed  Google Scholar 

  • Peltier P, Curtet C, Chatal JF, le Doussal JM, Daniel G, Aillet G, Gruaz-Guyon A, Barbet J, Delaage M (1993) Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA, anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med 34:1267–1273

    PubMed  Google Scholar 

  • Quaedvlieg PF, Visser O, Lamers CB, Janssen-Heijen ML, Taal BG (2001) Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiology study with 2391 patients. Ann Oncol 12:1295–1300

    Article  PubMed  Google Scholar 

  • Schauer A, Aures D, Hakanson R, Clark WG (1968) Zellulare Lokalisation und physiologische Bedeutung von Aminosauredecarboxylasen. Verh Dtsch Ges Pathol 52: 356–361

    PubMed  Google Scholar 

  • Seregni E, Ferrari L, Bajetta E, Martinetti A, Bombardieri E (2001) Clinical significance of blood chromogranin A measurement in neuroendocrine tumors. Ann Oncol 12[Suppl 23]:S69–S72

    Article  Google Scholar 

  • Soga J (1997) Gastric carcinoids: a statistical evaluation of 1094 cases collected from the literature. Surg Today 27: 892–901

    PubMed  Google Scholar 

  • Stivanello M, Berruti A, Torta M, Termine A, Tampellini M, Gorzegno G, Angeli A, Dogliotti L (2001) Circulating chromogranin A in the assessment of patients with neuroendocrine tumors. A single institution experience. Ann Oncol 12[Suppl 2]:S73–S77

    Article  PubMed  Google Scholar 

  • Tomassetti P, Migliori M, Caletti GC, Fusaroli P, Corinaldesi R, Gullo L (2000) Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med 343: 551–554

    Article  PubMed  Google Scholar 

  • Travis W, Linnoila R, Tsokos M, Hitchcock C, Cutler G, Niemann L, Chrousos G, Pass H, Doppman J (1991) Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. Am J Surg Pathol 15(6):529–533

    PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schauer, A., Schauer, M., Ritzel, U. (2005). SLN Staging in Carcinoids and Neuroendocrine Tumors. In: The Sentinel Lymph Node Concept. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26393-4_27

Download citation

  • DOI: https://doi.org/10.1007/3-540-26393-4_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-41041-6

  • Online ISBN: 978-3-540-26393-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics